Skip to main content
. 2022 Jan 25;12:781946. doi: 10.3389/fpsyt.2021.781946

Table 6.

Relative risk of the common side effects induced by DRPAs (modified from 4, 76).

Aripiprazole Brexpiprazole Cariprazine
Akathisia + +/– +
EPS + + +
Anxiety ++ + +
Sedation + +/– +/–
Weight gain + ++ +
Metabolic effects + + +
Hyperprolactinemia +/– + +/–
Nausea/vomiting + +/– +
Insomnia + +/– +/–
Impulse control symptoms/compulsive behaviors + +/– +/–
QTc prolongation + + +
Postural hypotension + + +

EPS, extrapyramidal symptoms; +/-, very low; +, low; ++, moderate.